Results 301 to 310 of about 2,061,642 (403)
Multidirectional therapeutic effects of synthesized HMGB1 peptide on liver cirrhosis in mice. [PDF]
Mito M+9 more
europepmc +1 more source
Editorial: Treatment and prognostic assessment of liver cirrhosis and its complications, volume II
Wei Zhang+5 more
doaj +1 more source
INFECTIVE HEPATITIS AND CIRRHOSIS OF THE LIVER<sup>1</sup>
P. B. Fernando, R. S. THANABALASUNDERAM
openalex +1 more source
Comparison of Zinc Levels in Liver Cirrhosis and Evaluating the Severity Using Child-Pugh Score. [PDF]
Kakumanu V, Mantur PG.
europepmc +1 more source
Rewriting the MASLD‐associated hepatocellular carcinoma script: Targeting epigenetics and metabolism
Abstract Abnormal epigenetic patterns are crucial for the progression of metabolic‐associated steatotic liver disease (MASLD) and hepatocellular carcinoma (HCC) development. Recent research focused on the interplay between epigenetics and altered metabolic pathways in HCC from MASLD, suggesting that the reversibility of epigenetic changes offers ...
Chiara Aiello+7 more
wiley +1 more source
Activation of lymphangiogenesis by platelet as novel therapeutic approaches for liver cirrhosis and portal hypertension. [PDF]
Li JF+6 more
europepmc +1 more source
What's New? Alcohol's prognostic role in colorectal cancer remains uncertain, partly due to biases in self‐reported intake. This is the first study to evaluate blood DNA methylation‐based alcohol consumption scores as prognostic biomarkers in colorectal cancer.
Tanwei Yuan+8 more
wiley +1 more source
Chronic Infectious Hepatitis (The anicteric form and its change to cirrhosis of the liver)
Tosaku Maeda
openalex +2 more sources